MedPath

The effect of Probiotics on control of clinical features of Bronchiectasis

Phase 2
Recruiting
Conditions
bronchiectasis.
Bronchiectasis
Registration Number
IRCT2017041514085N4
Lead Sponsor
Vice Chancellar of Research of Guilan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
60
Inclusion Criteria

More than 18 years, Not being Pregnant;
Exclusion criteria: Cardiovascular diseases; Diabetes; Use of immunosuppressive agents; Bronchiectasis due to foreign body or tumor; Disable to do spirometry

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Severity of cough. Timepoint: The same 6 month of last year and at during of intervention. Method of measurement: by asking the person.;Amount of sputum. Timepoint: The same 6 month of last year and before of intervention and end of sixth months. Method of measurement: by asking the person.;Severity of dyspnea. Timepoint: The same 6 month of last year and at during of intervention. Method of measurement: by asking the person base on MRC scale.;Results of sputum culture. Timepoint: before of intervention and end of sixth month. Method of measurement: smear and anti biogram.;FEV1, FVC, FEV1/FVC. Timepoint: before of intervention and end of sixth month. Method of measurement: spirometry.;Body mass index. Timepoint: before of intervention and end of sixth month. Method of measurement: weight over square of height.
Secondary Outcome Measures
NameTimeMethod
eed of prophylactic antibiotic for disease exacerbation. Timepoint: during of intervention. Method of measurement: by asking the person.;Rate of hospitalizations. Timepoint: during of intervention. Method of measurement: by asking the person.;Rate of exacerbation of disease. Timepoint: during of intervention. Method of measurement: by asking the person.
© Copyright 2025. All Rights Reserved by MedPath